Notification of Policy Revisions Effective October 1, 2021 (Posted July 1, 2021)
Policy Name | Revision |
Intravenous Iron Replacement Therapy “Notification” | Original medical policy criteria issued. Policy notification given 7/1/2021 for effective date 10/1/2021. |
Ocular Angiogenesis Inhibitor Agents “Notification” | Original medical policy criteria issued. Policy notification given 7/1/2021 for effective date 10/1/2021. |